Item 2 Issuer Principal Place of Business and Contact Information
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
Phone Number:
subscription required
Item 3. Related Persons
Name
KEVIN W SHARER
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
ROBERT A BRADWAY
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
DAVID W BEIER
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
FABRIZIO BONANNI
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
SEAN E. HARPER
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
ANTHONY C. HOOPER
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
BRIAN M MCNAMEE
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
JONATHAN M PEACOCK
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
ANNA S RICHO
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
DAVID J SCOTT
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
THOMAS DITTRICH
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
DAVID BALTIMORE
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
FRANK J BIONDI, JR.
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
VANCE D COFFMAN
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
FRANCOIS DE CARBONNEL
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
REBECCA HENDERSON
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
FRANK C HERRINGER
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
GILBERT S OMENN
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
JUDITH C PELHAM
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
J PAUL REASON
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
LEONARD D SCHAEFFER
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
RONALD D SUGAR
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
06
Item 7. Type of Filing
Amendment
Date of First Sale in this Offering:
09/28/2011
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
Yes
Item 9. Type(s) of Securities Offered
Other: COMMERCIAL PAPER
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
250000
Item 12. Sales Compensation
Recipient
GOLDMAN, SACHS CO.
Recipient CRD Number
361
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
200 WEST STREET
NEW YORK, NY 10282
States of Solicitation
ALL STATES
Item 12. Sales Compensation
Recipient
BARCLAYS CAPITAL INC
Recipient CRD Number
19714
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
745 7TH AVENUE
NEW YORK, NY 10019
States of Solicitation
ALL STATES
Item 12. Sales Compensation
Recipient
CITIGROUP GLOBAL MARKETS INC.
Recipient CRD Number
7059
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
388 GREENWICH STREET
NEW YORK, NY 10013
States of Solicitation
ALL STATES
Item 12. Sales Compensation
Recipient
BANC OF AMERICA SECURITIES LLC
Recipient CRD Number
26091
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
ONE BRYANT PARK
NEW YORK, NY 10036
States of Solicitation
ALL STATES
Item 12. Sales Compensation
Recipient
MORGAN STANLEY CO. INCORPORATED
Recipient CRD Number
8209
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
1585 BROADWAY
NEW YORK, NY 10036
States of Solicitation
ALL STATES
Item 12. Sales Compensation
Recipient
DEUTSCHE BANK SECURITIES INC.
Recipient CRD Number
2525
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
60 WALL STREET
NEW YORK, NY 10005
States of Solicitation
ALL STATES
Item 13. Offering and Sales Amounts
Total Offering Amount
2500000000
Total Amount Sold
0
Total Remaining to be Sold
2500000000
Clarification of Response
THIS IS A CONTINUOUS COMMERCIAL PAPER PROGRAM. THE TOTAL AMOUNT OFFERED REPRESENTS THE MAXIMUM AUTHORIZED AMOUNT. AS OF THE DATE OF THIS FILING, NO AMOUNTS ARE OUTSTANDING UNDER THIS PROGRAM.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
34
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
750000.0 Is an estimate
Finders' Fees
0.0
Clarification of Response
ANNUALIZED ESTIMATE BASED ON THE TOTAL OFFERING AMOUNT OF THE PROGRAM.
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Notice has been signed on behalf by the undersigned duly authorized person
Issuer Name
AMGEN INC
Issuer Signature
/S/ DAVID J.SCOTT
Signer Name
DAVID J.SCOTT
Signer Title
SENIOR VICE PRESIDENT, GENERAL COUNSEL AND SECRETARY